Form D/A — SV8 Biotech Fund LP
0002070013-26-000001 · filed Jun 29, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Reported offering amount
- —
- Reported amount sold
- $70,000,000
- Minimum investment
- $0
- Investors
- 3
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- SV8 Biotech Fund LP
- CIK
- 2070013
- Entity
- Limited Partnership
- Jurisdiction
- UNITED KINGDOM
- Year incorporated
- 2025
- Address
- 71 KINGSWAY
LONDON, X0 WC2B 6ST - Phone
- 44 20 7421 7081
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- SV Health Managers LLP · Executive OfficerLondon, X0 Find on LinkedIn ↗
-
- SV8 Bio GP LLP · Executive OfficerLondon, X0 Find on LinkedIn ↗
-
James Costine · Executive OfficerLondon, X0 Find on LinkedIn ↗
-
Kate Bingham · Executive OfficerLondon, X0 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗